Results
|
23681.
|
|
|
23682.
|
|
|
23683.
|
|
|
23684.
|
|
|
23685.
|
|
|
23686.
|
|
|
23687.
|
|
|
23688.
|
|
|
23689.
|
|
|
23690.
|
|
|
23691.
|
|
|
23692.
|
|
|
23693.
|
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group. [electronic resource] by
- Hughes, W
- Dorenbaum, A
- Yogev, R
- Beauchamp, B
- Xu, J
- McNamara, J
- Moye, J
- Purdue, L
- van Dyke, R
- Rogers, M
- Sadler, B
Producer: 19980813
In:
Antimicrobial agents and chemotherapy vol. 42
Availability: No items available.
|
|
23694.
|
|
|
23695.
|
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. [electronic resource] by
- Fujiwara, T
- Sato, A
- el-Farrash, M
- Miki, S
- Abe, K
- Isaka, Y
- Kodama, M
- Wu, Y
- Chen, L B
- Harada, H
- Sugimoto, H
- Hatanaka, M
- Hinuma, Y
Producer: 19980813
In:
Antimicrobial agents and chemotherapy vol. 42
Availability: No items available.
|
|
23696.
|
|
|
23697.
|
|
|
23698.
|
|
|
23699.
|
|
|
23700.
|
|